Dr. Kalmadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
695 S Dobson Rd
Chandler, AZ 85224Phone+1 480-821-2838Fax+1 480-821-9444- Is this information wrong?
Education & Training
- Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2003 - 2006
- Cleveland Clinic FoundationResidency, Internal Medicine/Pediatrics, 1995 - 1999
- Henry Ford HospitalInternship, Transitional Year, 1994 - 1995
- Kasturba Medical College ManipalClass of 1994
Certifications & Licensure
- AZ State Medical License 2008 - 2024
- OH State Medical License 1997 - 2008
- TX State Medical License 2007 - 2008
- FL State Medical License 1999 - 2004
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
Publications & Presentations
PubMed
- 9 citationsTumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on o...Ticiana Leal, Rupesh Kotecha, Rodryg Ramlau, Li Zhang, Janusz Milanowski, Manuel Cobo, Jaromir Roubec, Lubos Petruzelka, Libor Havel, Sujith Kalmadi, Jeffrey Ward, Zor...> ;The Lancet. Oncology. 2023 Sep 1
- 5 citationsExpert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region.Milan J Anadkat, Mario Lacouture, Adam Friedman, Zachary D Horne, Jae Jung, Benjamin Kaffenberger, Sujith Kalmadi, Liza Ovington, Rupesh Kotecha, Huda Ismail Abdullah,...> ;Frontiers in Oncology. 2022 Jan 1
- 6 citationsMulticenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem, Svetomir N. Markovic, Tawnya L. Bowles, Omid Hamid, Leonel Hernandez-A...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
- Join now to see all
Press Mentions
- The 100 Best Doctors in Arizona for 2024December 15th, 2023
Professional Memberships
- Member
- Member
Hospital Affiliations
- Chandler Regional Medical CenterChandler, Arizona
- Mercy Gilbert Medical CenterGilbert, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: